Stay updated on Comparing Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Comparing Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Uproleselan in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov software revision has been updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T04:41:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The history now includes a new revision entry v3.5.2 and removes v3.5.0 from the history log.
    Difference
    0.1%
    Check dated 2026-04-16T21:33:54.000Z thumbnail image
  4. Check
    45 days ago
    Change Detected
    Summary
    Revision history updated: added version 3.5.0 and removed version 3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:14.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 added to the study record history.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:12.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the study record history. The outdated government-funding notice and the previous revision entry (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-11T14:23:09.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and updated the revision tag to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:30:28.000Z thumbnail image

Stay in the know with updates to Comparing Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Uproleselan in AML Clinical Trial page.